Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical studies of JAG-101, a gene therapy for type 1 galactosemia

May 20, 2022

HDAC6 inhibitor CKD-510 shows promise for the treatment of CMT1A

May 20, 2022

Novel mouse models of RP59 retinal degeneration

May 20, 2022

Chulalongkorn University presents compounds for treating hepatitis B virus infections

May 20, 2022

Spectrum Pharmaceuticals divulges G12C mutant GTPase KRAS inhibitors

May 20, 2022

Mount Sinai School of Medicine patents ATP6V1A gene expression enhancers

May 20, 2022

New CTP synthase 1 inhibitors discovered at Nimbus Clotho

May 20, 2022

Auransa identifies new agents for bacterial and fungal infections

May 20, 2022

CD70-CAR NK cells have cytotoxic effects against osteosarcoma

May 20, 2022

ROR2 CAR T cells exhibit cytotoxic effects against tumoral cells

May 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...